When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMF - Astellas in-licenses rights to hearing loss candidate
Astellas Pharma Inc
Astellas Pharma (OTCPK:ALPMF) inks an agreement with Woburn, MA-based Frequency Therapeutics to co-develop and commercialize a regenerative therapeutic candidate, FX-322, for the treatment of sensorineural hearing loss.
More news on: Astellas Pharma Inc., Astellas Pharma Inc., Healthcare stocks news,